861 related articles for article (PubMed ID: 28011307)
1. The olfactory bulb as the entry site for prion-like propagation in neurodegenerative diseases.
Rey NL; Wesson DW; Brundin P
Neurobiol Dis; 2018 Jan; 109(Pt B):226-248. PubMed ID: 28011307
[TBL] [Abstract][Full Text] [Related]
2. Spread of aggregates after olfactory bulb injection of α-synuclein fibrils is associated with early neuronal loss and is reduced long term.
Rey NL; George S; Steiner JA; Madaj Z; Luk KC; Trojanowski JQ; Lee VM; Brundin P
Acta Neuropathol; 2018 Jan; 135(1):65-83. PubMed ID: 29209768
[TBL] [Abstract][Full Text] [Related]
3. Olfactory bulb involvement in neurodegenerative diseases.
Attems J; Walker L; Jellinger KA
Acta Neuropathol; 2014 Apr; 127(4):459-75. PubMed ID: 24554308
[TBL] [Abstract][Full Text] [Related]
4. Neurodegenerative changes in the brainstem and olfactory bulb in people older than 50 years old: a descriptive study.
Oliveira FH; Rodrigues Neto E; Fonseca MK; Costa AS; Rockenbach MA; Padilha Rdos S; Fernandez LL; Hilbig A
Arq Neuropsiquiatr; 2015 Jul; 73(7):569-77. PubMed ID: 26200050
[TBL] [Abstract][Full Text] [Related]
5. Mitral cells and the glucagon-like peptide 1 receptor: The sweet smell of success?
Bagnoli E; FitzGerald U
Eur J Neurosci; 2019 Feb; 49(4):422-439. PubMed ID: 30120857
[TBL] [Abstract][Full Text] [Related]
6. Tau pathology in the olfactory bulb correlates with Braak stage, Lewy body pathology and apolipoprotein epsilon4.
Tsuboi Y; Wszolek ZK; Graff-Radford NR; Cookson N; Dickson DW
Neuropathol Appl Neurobiol; 2003 Oct; 29(5):503-10. PubMed ID: 14507342
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of olfactory dysfunction in aging and neurodegenerative disorders.
Kovács T
Ageing Res Rev; 2004 Apr; 3(2):215-32. PubMed ID: 15177056
[TBL] [Abstract][Full Text] [Related]
8. Amyloid-β deposition and olfactory dysfunction in an Alzheimer's disease model.
Wu N; Rao X; Gao Y; Wang J; Xu F
J Alzheimers Dis; 2013; 37(4):699-712. PubMed ID: 23948910
[TBL] [Abstract][Full Text] [Related]
9. A ventral glomerular deficit in Parkinson's disease revealed by whole olfactory bulb reconstruction.
Zapiec B; Dieriks BV; Tan S; Faull RLM; Mombaerts P; Curtis MA
Brain; 2017 Oct; 140(10):2722-2736. PubMed ID: 28969383
[TBL] [Abstract][Full Text] [Related]
10. The human olfactory system in two proteinopathies: Alzheimer's and Parkinson's diseases.
Ubeda-Bañon I; Saiz-Sanchez D; Flores-Cuadrado A; Rioja-Corroto E; Gonzalez-Rodriguez M; Villar-Conde S; Astillero-Lopez V; Cabello-de la Rosa JP; Gallardo-Alcañiz MJ; Vaamonde-Gamo J; Relea-Calatayud F; Gonzalez-Lopez L; Mohedano-Moriano A; Rabano A; Martinez-Marcos A
Transl Neurodegener; 2020 Jun; 9(1):22. PubMed ID: 32493457
[TBL] [Abstract][Full Text] [Related]
11. Heat shock protein responses to aging and proteotoxicity in the olfactory bulb.
Crum TS; Gleixner AM; Posimo JM; Mason DM; Broeren MT; Heinemann SD; Wipf P; Brodsky JL; Leak RK
J Neurochem; 2015 Jun; 133(6):780-794. PubMed ID: 25640060
[TBL] [Abstract][Full Text] [Related]
12. Alzheimer's disease and alpha-synuclein pathology in the olfactory bulbs of infants, children, teens and adults ≤ 40 years in Metropolitan Mexico City. APOE4 carriers at higher risk of suicide accelerate their olfactory bulb pathology.
Calderón-Garcidueñas L; González-Maciel A; Reynoso-Robles R; Kulesza RJ; Mukherjee PS; Torres-Jardón R; Rönkkö T; Doty RL
Environ Res; 2018 Oct; 166():348-362. PubMed ID: 29935448
[TBL] [Abstract][Full Text] [Related]
13. α-Synuclein conformational strains spread, seed and target neuronal cells differentially after injection into the olfactory bulb.
Rey NL; Bousset L; George S; Madaj Z; Meyerdirk L; Schulz E; Steiner JA; Melki R; Brundin P
Acta Neuropathol Commun; 2019 Dec; 7(1):221. PubMed ID: 31888771
[TBL] [Abstract][Full Text] [Related]
14. Increased amoeboid microglial density in the olfactory bulb of Parkinson's and Alzheimer's patients.
Doorn KJ; Goudriaan A; Blits-Huizinga C; Bol JG; Rozemuller AJ; Hoogland PV; Lucassen PJ; Drukarch B; van de Berg WD; van Dam AM
Brain Pathol; 2014 Mar; 24(2):152-65. PubMed ID: 24033473
[TBL] [Abstract][Full Text] [Related]
15. Inducible dopaminergic glutathione depletion in an α-synuclein transgenic mouse model results in age-related olfactory dysfunction.
Kim YH; Lussier S; Rane A; Choi SW; Andersen JK
Neuroscience; 2011 Jan; 172():379-86. PubMed ID: 21055449
[TBL] [Abstract][Full Text] [Related]
16. Propagation of alpha-synuclein pathology from the olfactory bulb: possible role in the pathogenesis of dementia with Lewy bodies.
Cersosimo MG
Cell Tissue Res; 2018 Jul; 373(1):233-243. PubMed ID: 29196808
[TBL] [Abstract][Full Text] [Related]
17. Co-localization of tau and alpha-synuclein in the olfactory bulb in Alzheimer's disease with amygdala Lewy bodies.
Fujishiro H; Tsuboi Y; Lin WL; Uchikado H; Dickson DW
Acta Neuropathol; 2008 Jul; 116(1):17-24. PubMed ID: 18446351
[TBL] [Abstract][Full Text] [Related]
18. Perturbation of in vivo Neural Activity Following α-Synuclein Seeding in the Olfactory Bulb.
Kulkarni AS; Del Mar Cortijo M; Roberts ER; Suggs TL; Stover HB; Pena-Bravo JI; Steiner JA; Luk KC; Brundin P; Wesson DW
J Parkinsons Dis; 2020; 10(4):1411-1427. PubMed ID: 32925105
[TBL] [Abstract][Full Text] [Related]
19. Olfactory dysfunctions in neurodegenerative disorders.
Ruan Y; Zheng XY; Zhang HL; Zhu W; Zhu J
J Neurosci Res; 2012 Sep; 90(9):1693-700. PubMed ID: 22674288
[TBL] [Abstract][Full Text] [Related]
20. A 100% increase of dopaminergic cells in the olfactory bulb may explain hyposmia in Parkinson's disease.
Huisman E; Uylings HB; Hoogland PV
Mov Disord; 2004 Jun; 19(6):687-92. PubMed ID: 15197709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
